Epidermal growth factor receptor tyrosine kinase inhibition is not protective in PCK rats
- 1 November 2004
- journal article
- Published by Elsevier in Kidney International
- Vol. 66 (5) , 1766-1773
- https://doi.org/10.1111/j.1523-1755.2004.00952.x
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- EGF receptor tyrosine kinase inhibition attenuates the development of PKD in Han:SPRD ratsKidney International, 2003
- Combination treatment of PKD utilizing dual inhibition of EGF-receptor activity and ligand bioavailabilityKidney International, 2003
- Genetics and Pathogenesis of Polycystic Kidney DiseaseJournal of the American Society of Nephrology, 2002
- A novel inhibitor of tumor necrosis factor-α converting enzyme ameliorates polycystic kidney diseaseKidney International, 2001
- Renal dysfunction but not cystic change is ameliorated by neonatal epidermal growth factor in bpk micePediatric Nephrology, 2001
- Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitorKidney International, 2000
- Activation of Gsα by the Epidermal Growth Factor Receptor Involves PhosphorylationJournal of Biological Chemistry, 1996
- Epidermal growth factor receptor expression is abnormal in murine polycystic kidneyKidney International, 1995
- Defective epidermal growth factor gene expression in mice with polycystic kidney diseaseDevelopmental Biology, 1990
- Epidermal growth factor inhibits the hydroosmotic effect of vasopressin in the isolated perfused rabbit cortical collecting tubule.Journal of Clinical Investigation, 1988